Trade Summary

3 days ago, AH Equity Partners Bio II, L.L.C., serving as 10% owner Owner at Nautilus Biotechnology, Inc. (NAUT), sold 5,000,000 shares at $2.35 per share, for a total transaction value of $11,750,000.00. Following this transaction, AH Equity Partners Bio II, L.L.C. now holds 971,885 shares of NAUT.

This sale represents a 83.73% decrease in AH Equity Partners Bio II, L.L.C.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, June 2, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 4, 2026 at 4:53 PM ET, 2 days after the trade was made.

Nautilus Biotechnology, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.